Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents with Narcolepsy

- Narcolepsy
- Completed

Study Title: Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Teva Identifier: C10953/1100 | 2012-005510-20

ClinicalTrials.gov Identifier: NCT01624480

Study Status: Completed

Trial Condition(s): Narcolepsy

Interventions: Drug: Armodafinil

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 6 Years to 17 Years

Trial Duration: 07/01/2012 - 12/01/2015

Phase: Phase 1

Study Type

Interventional